Overactive Bladder

The purpose of the study:

To demonstrate the greater efficacy of 8 mg of Fesoterodine compared to 4 mg Fesoterodine in reducing urinary urgency incontinence in subjects with OAB after 12 weeks of treatment.

Duration:

14 weeks

Number of visits:

3 office visits and 2 telephone visits

Compensation:

Up to $180

Qualifications and Notes:

Note: Qualified participants must void 8 or more times in 24 hr period and have an average of at least 2 urinary urgency incontinence episodes in 24 hr.